Patients with severe forms of Alzheimer’s disease should stay on Pfizer’s Aricept for longer, according to new research. A new …
Eisai’s planned job cuts will fall heaviest on its US operations, where 20% of the workforce will be let go …
Eisai is to cut around 900 jobs in Europe, the US and Japan over the next five years as it …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

